Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Acinar Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00769483
What this trial is testing

MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic Adenocarcinoma
M.D. Anderson Cancer Center 81
Early research (Phase 1)Ended earlyNCT01946646
What this trial is testing

Phase I Study of TS-1 With Concurrent Radiotherapy to Treat Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
National Taiwan University Hospital 10
Testing effectiveness (Phase 2)Study completedNCT00922896
What this trial is testing

Trial of Erlotinib, Gemcitabine and Cisplatin in Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Gyeongsang National University Hospital 22
Very early researchUnknownNCT05275062
What this trial is testing

Clinical Trial to Evaluate the Safety and Efficacy of IM92 CAR-T Cells Therapy in Patients With Advanced Gastric or Pancreatic Adenocarcinoma

Who this might be right for
Advanced Solid TumorsGastric CancerEsophagogastric Junction Cancer+1 more
Beijing Immunochina Medical Science & Technology Co., Ltd. 6
Early research (Phase 1)Study completedNCT00294203
What this trial is testing

Pilot Study of Epoetin Alfa for Patients Having Abdominal or Pelvic Surgery for Cancer

Who this might be right for
Anemia
University of Florida 40
Early research (Phase 1)Ended earlyNCT02132403
What this trial is testing

(PM-01) IMPRIME PGG® With BTH1704 and Gemcitabine for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Illinois at Chicago 3
Early research (Phase 1)Active Not RecruitingNCT06059001
What this trial is testing

Study to Evaluate the Safety, PK, and Efficacy of the Myc Inhibitor OMO-103 Administered iv in Patients With PDAC

Who this might be right for
Metastatic Pancreatic Cancer
Peptomyc S.L. 26
Not applicableUnknownNCT01641003
What this trial is testing

Isolation and Characterization of Cancer Stem Cells Using iFP Technique

Who this might be right for
Malignant Neoplasm of BreastGliomaPancreatic Cancer
Rambam Health Care Campus 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT04940286
What this trial is testing

Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaResectable Pancreatic AdenocarcinomaStage IA Pancreatic Cancer AJCC v8+3 more
M.D. Anderson Cancer Center 13
Not applicableEnded earlyNCT05515705
What this trial is testing

First-in-human Navigation Endoscopic Ultrasound (EUS) System Clinical Study

Who this might be right for
Pancreatic Disease
IHU Strasbourg 21
Testing effectiveness (Phase 2)Looking for participantsNCT05417594
What this trial is testing

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Who this might be right for
Advanced Solid Malignancies
AstraZeneca 695
Testing effectiveness (Phase 2)Study completedNCT01064622
What this trial is testing

Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaRecurrent Pancreatic CarcinomaStage IV Pancreatic Cancer AJCC v6 and v7
National Cancer Institute (NCI) 118
Testing effectiveness (Phase 2)Study completedNCT00003951
What this trial is testing

DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas

Who this might be right for
Pancreatic Cancer
Daiichi Sankyo 37
Not applicableStudy completedNCT01615653
What this trial is testing

EUS Guided Celiac Neurolysis

Who this might be right for
Pancreatic Cancer Pain
Mayo Clinic 110
Not applicableLooking for participantsNCT03937453
What this trial is testing

A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus

Who this might be right for
Pancreatic CancerPancreatic NeoplasmsDiabetes Mellitus
Nuvance Health 800
Testing effectiveness (Phase 2)Temporarily pausedNCT00209677
What this trial is testing

Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Hokkaido Gastrointestinal Cancer Study Group 40
Testing effectiveness (Phase 2)Study completedNCT05538195
What this trial is testing

Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors

Who this might be right for
Gastric CancerColon CancerRectal Cancer+2 more
Chongqing Precision Biotech Co., Ltd 17
Not applicableUnknownNCT05830019
What this trial is testing

Carbon Ion Radiotherapy for Recurrent Pancreatic Cancer Post Surgery

Who this might be right for
Pancreatic Carcinoma
Shanghai Proton and Heavy Ion Center 49
Not applicableUnknownNCT04049461
What this trial is testing

Heterotopic Ossification in Abdominal Incision and Pancreatic Cancer

Who this might be right for
Cancer of PancreasOssification, Heterotopic
Nanjing Medical University 105
Large-scale testing (Phase 3)UnknownNCT03317886
What this trial is testing

Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreaticoduodenectomyMesenteric Approach
Wakayama Medical University 354
Next Page